Mitoxantrone hydrochloride is a synthetically derived anthracenedione compound supplied as a pharmaceutical raw material. It is used in the manufacturing of antineoplastic formulations, primarily for research and industrial pharmaceutical applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 70476-82-3
Altretamine
pharmaceutical raw material
Ingenol mebutate
pharmaceutical raw material
Ixabepilone
pharmaceutical raw material
Betulinic acid
pharmaceutical raw material
Vorapaxar sulfate
pharmaceutical raw material
Kanamycin sulfate mixture OF components A,B and C
pharmaceutical raw material
Catharanthine sulfate
pharmaceutical raw material
Pimavanserin
pharmaceutical raw material
The international HS code for Mitoxantrone hydrochloride (CAS 70476-82-3) is 2922.50.
2922.50
2922 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride
ZAHQPTJLOCWVPG-UHFFFAOYSA-N
C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl